Precise Biometrics AB's next confirmed earnings release is scheduled for November 13, 2026.
| Earnings Date | 11/13/2026 |
As of June 30, 2026, Precise Biometrics AB has 49.55M shares outstanding.
| Shares Outstanding | 49.55M |
As of June 30, 2026, Precise Biometrics AB maintains a current ratio of 0.93, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.93 |
| Quick Ratio | 0.52 |
| Debt / Equity | 9.43 |
| Debt / EBITDA | -0.45 |
Over the twelve months ended June 30, 2026, Precise Biometrics AB posted a negative return on equity (ROE) of -18.13, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -13.03, reflecting losses generated across the asset base. The company generates approximately 173,824.81 in revenue per employee across its workforce of 35.75, a quick read on workforce productivity versus industry peers. Inventory turnover of 89.36 indicates how many times Precise Biometrics AB sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Equity (ROE) | -18.13 |
| Return on Assets (ROA) | -13.03 |
| Revenue Per Employee | 173,824.81 |
| Employee Count | 35.75 |
| Inventory Turnover | 89.36 |
Over the twelve months ended June 30, 2026, Precise Biometrics AB recorded an income tax benefit of -31,418.32 rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -2.10M and -2.07M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.
| Income Tax | -31,418.32 |
Over the twelve months ended June 30, 2026, Precise Biometrics AB generated 6.21M in revenue and converted that into -2.07M in net income, yielding earnings per share of -0.08. EBITDA reached -2.16M, while operating income came in at -2.16M.
| Revenue | 6.21M |
| Gross Profit | 4.44M |
| Operating Income | -2.16M |
| Pretax Income | -2.10M |
| Net Income | -2.07M |
| EBITDA | -2.16M |
| EBIT | -2.16M |
| Earnings Per Share (EPS) | -0.08 |
As of June 30, 2026, Precise Biometrics AB holds 1.71M in cash and equivalents against 981,912.84 in total debt, resulting in a net debt position of -1.71M. Total book value stands at 10.41M, with working capital of -232,206.68 providing operational flexibility.
| Cash & Cash Equivalents | 1.71M |
| Total Debt | 981,912.84 |
| Net Debt | -1.71M |
| Equity (Book Value) | 10.41M |
| Book Value Per Share | 0.21 |
| Working Capital | -232,206.68 |
Precise Biometrics AB produced 517,950.90 in operating cash flow over the twelve months ended June 30, 2026. After subtracting -1.11M in capital expenditures, free cash flow totaled -589,815.79 - equivalent to -0.02 per share.
| Operating Cash Flow | 517,950.90 |
| Capital Expenditures | -1.11M |
| Free Cash Flow | -589,815.79 |
| FCF Per Share | -0.02 |
Over the twelve months ended June 30, 2026, Precise Biometrics AB posted a gross margin of 71.44, reflecting its pricing power and cost economics. The operating margin of -34.81 and net profit margin of -33.36 provide insight into operational efficiency.
| Gross Margin | 71.44 |
| Operating Margin | -34.81 |
| Pretax Margin | -33.87 |
| Profit Margin | -33.36 |
| EBITDA Margin | -34.81 |
Precise Biometrics AB's most recent stock split took place on May 11, 2023 with a 41:47 split ratio.
| Last Split Date | 5/11/2023 |
| Split Ratio | 41:47 |
Already premium?